Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping the price target at $3.20. Richard Close has given his Buy ...

Clover Health Investments, Corp. (NASDAQ:CLOV), a healthcare insurance provider, has agreed to pay $250,000 in legal fees to resolve a dispute over its board nomination process.... FRANKLIN, Tenn.

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025. What To Know ...

FRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today ...

Clover Health Medicare Advantage plans are available in five states and get average star ratings from CMS. Many, or all, of the products featured on this page are from our advertising partners who ...

For example, Clover Health Investments (NASDAQ:CLOV) shareholders have done very well over the last year, with the share price soaring by 330%. Nonetheless, only a fool would ignore the risk that ...

Featured here, the Balance Sheet for Clover Health Investments Corp, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. Counterpart Health is Clover’s AI assistant tool for physicians. It is sold ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...